Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae

Clinical and Vaccine Immunology

Volumn 13, Issue 4, 2006, Pages 459-466

  Martinez, Joseph E ^a,b   Clutterbuck, Elizabeth A ^a   Li, Han ^a   Romero Steiner, Sandra ^a   Carlone, George M ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE; REDUCING AGENT;

ANTIBODY DETECTION; ARTICLE; BACTERICIDAL ACTIVITY; BLOOD SAMPLING; EVALUATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNIZATION; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TECHNIQUE;

ADULT; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HL-60 CELLS; HUMANS; OPSONIN PROTEINS; PHAGOCYTOSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 33745913028     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.13.4.459-466.2006     Document Type: Article

References (21)

1. Ali, F., M. E. Lee, F. Iannelli, G. Pozzi, T. J. Mitchell, R. C. Read, and D. H. Dockrell. 2003. Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcγ receptors correlates with intracellular bacterial load. J. Infect. Dis. 188:1119-1131.
2. Bassoe, C. F., I. Smith, S. Sornes, A. Halstensen, and A. K. Lehman. 2000. Concurrent measurement of antigen- and antibody-dependent oxidative burst and phagocytosis in monocytes and neutrophils. Methods 21:203-220.
3. Bogaert, D., M. Sluijter, R. de Groot, and P. W. M. Hermans. 2004. Multiplexed opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine. Vaccine 22:4014-4020.
4. Casal, J., and Tarrago, D. 2003. Immunity to Streptococcus pneumonias: factors affecting production and efficacy. Curr. Opin. Infect. Dis. 16:219-224.
5. Centers for Disease Control and Prevention. 1997. Prevention of pneumococcal disease: recommendation of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 46(RR-8):1-24.
6. Centers for Disease Control and Prevention. 1989. Pneumococcal polysaccharide vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 38:64-68, 73-76.
7. Guckian, J. C., G. D. Christensen, and D. P. Fine. 2000. The role of opsonins in recovery from experimental pneumococcal pneumonia. J. Infect. Dis. 142:175-190.
8. Hu, B. T., X. Yu, T. R. Jones, C. Kirch, S. Harris, S. W. Hildreth, D. V. Madore, and S. A. Quataert. 2005. Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 12:287-295.
9. Jansen, W. T. M., J. Gootjes, M. Zelle, D. V. Madore, J. Verhoef, H. Snippe, and A. F. M. Verheul. 1998. Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometry assay for assessment of the phagocytic capacity of serotype specific antibodies. Clin. Diagn. Lab. Immunol. 5:703.
10. Jodar, L., J. Butler, G. Carlone, R. Dagan, D. Goldblatt, H. Kayhty, K. Klugman, B. Plikaytis, G. Siber, R. Kohberger, I. Chang, and T. Cherian. 2003. Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine 21:3265-3272.
11. Kim, K. H., J. Yu, and M. H. Nahm. 2003. Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies. Clin. Diagn. Lab. Immunol. 10:616-621.
12. Martinez, J., T. Pilishvili, S. Barnard, J. Caba, W. Spear, S. Romero-Steiner, and G. M. Carlone. 2002. Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity. Clin. Diagn. Lab. Immunol. 9:485-488.
13. Martinez, J. E., S. Romero-Steiner, T. Pilishvili, S. Barnard, J. Schinsky, D. Goldblatt, and G. M. Carlone. 1999. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with 23-valent pneumococcal polysaccharide vaccine. Clin. Diagn. Lab. Immunol. 6:581-586.
14. Nahm, M. H., D. E. Brile, and X. Yu. 2000. Development of a multispecificity opsonophagocytic killing assay. Vaccine 18:2768-2771.
15. Nahm, M. H., J. V. Olander, and M. Magyarlaki. 1997. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae. J. Infect. Dis. 176:698-703.
16. Romero-Steiner, S., C. Frasch, N. Concepcion, D. Goldblatt, H. Kayhty, M. Vakevainen, C. Laferriere, D. Wauters, M. Nahm, M. F. Schinsky, and B. D. Plikaytis. 2003. Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 10:1019-1024.
17. Romero-Steiner, S., D. LiButti, L. B. Pais, J. Dykes, P. Anderson, J. C. Whitin, H. L. Keyserling, and G. M. Carlone. 1997. Standardization of an opsonophagocytic assay for the measurement of the functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.
18. Romero-Steiner, S., D. M. Musher, M. S. Cetron, L. B. Pais, J. E. Groover, A. E. Fiore, B. D. Plikaytis, and G. M. Carlone. 1999. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin. Infect. Dis. 29:281-288.
19. Wernette, C. M., C. M. Frasch, D. Madore, G. Carlone, D. Goldblatt, B. Plikaytis, W. Benjamin, S. A. Quataet, S. Hildreath, D. J. Sikkema, H. Kayhty, I. Jonsdottir, and M. Nahm. 2003. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin. Diagn. Lab. Immunol. 10:514-519.
20. Winkelstein, J. A., M. R. Smith, and H. S. Shin. 1975. The role of C3 as an opsonin in the early stages of infection. Proc. Soc. Exp. Biol. Med. 149:397-401.
21. World Health Organization. 1999. Pneumococcal vaccines. Wkly. Epidemiol. Rec. 74:177-183.